Universal Health Services, Inc. (NYSE: UHS) has reported a significant increase in net income attributable to UHS for the third quarter of 2025, reaching $373.0 million, compared to $258.7 million for the same period in 2024. This represents a substantial increase of 44% year-over-year. The net revenues also saw a notable increase of 13.4% to $4.495 billion in the third quarter of 2025, compared to $3.963 billion in the third quarter of 2024.
Adjusted net income attributable to UHS during the third quarter of 2025 was $362.3 million, or $5.69 per diluted share, compared to $252.5 million, or $3.71 per diluted share, in the third quarter of 2024, demonstrating an impressive 43% increase in adjusted net income.
For the nine-month period ended September 30, 2025, reported net income attributable to UHS was $1.043 billion, or $16.07 per diluted share, representing a significant increase from $809.7 million, or $11.88 per diluted share, during the same period in 2024. This indicates a year-over-year increase of 29% in net income.
Net revenues for the first nine months of 2025 increased by 9.9% to $12.879 billion, compared to $11.714 billion during the same period in 2024.
In terms of operational performance, the acute care services segment saw a 12.8% increase in net revenues on a same facility basis during the third quarter of 2025 compared to the third quarter of 2024. For the first nine months of 2025, net revenues from acute care services on a same facility basis increased by 9.1% compared to the same period in 2024.
Behavioral health care services also showed positive growth, with a 9.3% increase in net revenues on a same facility basis during the third quarter of 2025 compared to the third quarter of 2024. For the first nine months of 2025, net revenues from behavioral health care services on a same facility basis increased by 7.9% compared to the same period in 2024.
Moreover, Universal Health Services, Inc. has revised its 2025 operating results forecast, increasing the forecasted range for consolidated net revenues and adjusted earnings before interest, taxes, depreciation & amortization. The revised forecast indicates a 1.0% increase in net revenues, a 3.9% increase in adjusted EBITDA, and a 6.4% increase in adjusted EPS-diluted over the previous forecast.
In addition, the company has announced a $1.5 billion increase to its stock repurchase program authorization, reflecting confidence in its financial position and future prospects. During the third quarter of 2025, the company repurchased 1.315 million shares at an aggregate cost of approximately $234.3 million, and during the first nine months of 2025, 3.190 million shares were repurchased at an aggregate cost of approximately $565.8 million.
As a result of these announcements, the company's shares have moved 1.59% on the market, and are now trading at a price of $214.03. For more information, read the company's full 8-K submission here.
